Additional file 8 of Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
We investigated circulating plasma EVs miRNA from 12 AML patients versus 12 healthy donors to identify a miRNA signature as a potential biomarker for patients with AML. Overall design: Plasma samples
Adult Acute Myeloid Leukemia [AML] is a heterogeneous disease with dismal outcome. Micro RNA [MiRNA] is a small endogenous non-coding RNA ranging from 18 to 22 nucleotides in size which has a major fu
A large-panel gene expression analysis was conducted to identify biomarkers associated with the effectiveness of adding palbociclib to fulvestrant Overall design: Baseline tumor tissue from PALOMA-3 t
